Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease

被引：0
|
作者：
Gkiouras, Konstantinos [1 ]
Grammatikopoulou, Maria G. [1 ,2 ]
Simopoulou, Theodora [1 ]
Daniil, Zoe [3 ]
Bogdanos, Dimitrios P. [1 ]
机构：
[1] Univ Thessaly, Dept Rheumatol & Clin Immunol, Fac Med, Sch Hlth Sci, Larisa, Greece
[2] Int Hellen Univ, Dept Nutr Sci & Dietet, Fac Hlth Sci, Alexander Campus, Thessaloniki, Greece
[3] Univ Thessaly, Dept Resp, Med Dept, Fac Med, Larisa, Greece
来源：
CLINICAL RHEUMATOLOGY | 2021年 / 40卷 / 08期
关键词：
METAANALYSES;
D O I：
10.1007/s10067-021-05845-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3379 / 3380
页数：2
相关论文
共 50 条
  • [31] Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial
    G. S. R. S. N. K. Naidu
    Shefali Khanna Sharma
    M. B. Adarsh
    Varun Dhir
    Anindita Sinha
    Sahajal Dhooria
    Sanjay Jain
    Rheumatology International, 2020, 40 : 207 - 216
  • [32] Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial
    Naidu, G. S. R. S. N. K.
    Sharma, Shefali Khanna
    Adarsh, M. B.
    Dhir, Varun
    Sinha, Anindita
    Dhooria, Sahajal
    Jain, Sanjay
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (02) : 207 - 216
  • [33] DEVELOPMENT OF A COMPOSITE OUTCOME MEASURE FOR SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE
    Volkmann, E.
    Li, N.
    Tashkin, D.
    Furst, D.
    Elashoff, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S28 - S28
  • [34] Distinct Immune Cell Subsets in Systemic Sclerosis-related Interstitial Lung Disease
    Saligrama, Phan
    Wilfong, Erin
    Rizzi, Elise
    Crofford, Leslie
    Kendall, Peggy
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2306 - 2307
  • [35] DEVELOPMENT OF A COMPOSITE OUTCOME MEASURE FOR SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE
    Volkmann, E.
    Li, N.
    Tashkin, D.
    Furst, D.
    Elashoff, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 165 - 165
  • [36] Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease
    Neslihan Yilmaz
    Yasin Abul
    Muge Bicakcigil
    Pejman Golabi
    Cigdem Celikel
    Sait Karakurt
    Sule Yavuz
    Rheumatology International, 2012, 32 : 1921 - 1925
  • [37] Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis
    Shell, J.
    Kapralik, J.
    Jones, A.
    Farooqi, M.
    Beattie, K.
    Kolb, M. R.
    Cox, G. P.
    Scallan, C. J.
    Larche, M. J.
    Khalidi, N. A.
    Hambly, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [38] Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease
    Yilmaz, Neslihan
    Abul, Yasin
    Bicakcigil, Muge
    Golabi, Pejman
    Celikel, Cigdem
    Karakurt, Sait
    Yavuz, Sule
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) : 1921 - 1925
  • [39] Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis-related interstitial lung diseases: a retrospective, observational cohort study
    Yilmaz, Deniz Demir
    Borekci, Sermin
    Musellim, Benan
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4071 - 4079
  • [40] MYCOPHENOLATE MOFETIL VERSUS AZATHIOPURINE FOR THE MAINTENANCE TREATMENT OF CONNECTIVE-TISSUE RELATED INTERSTITIAL LUNG DISEASE FOLLOWING CYCLOPHOSPHAMIDE TREATMENT
    Satis, H.
    Onut, M.
    Salman, R. Bilici
    Babaoglu, H.
    Atas, N.
    Guler, A. Avanoglu
    Karadeniz, H.
    Yapar, D.
    Kayahan, N.
    Haznedaroglu, S.
    Goker, B.
    Ozturk, M. A.
    Tufan, A.
    Turktas, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1206 - 1207
12345